Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLEKHM2 Inhibitors

PLEKHM2 inhibitors are a class of chemical compounds that have garnered significant attention in the field of molecular biology and cellular research. PLEKHM2, short for Pleckstrin homology domain-containing family M member 2, is a multifunctional protein that plays a crucial role in intracellular trafficking and autophagy processes within cells. These inhibitors are specifically designed to target and impede the function of PLEKHM2, thereby providing researchers with a valuable tool to dissect the intricate mechanisms governing vesicular transport and autophagy.

At the molecular level, PLEKHM2 inhibitors are typically small molecules or compounds that interact with specific regions of the PLEKHM2 protein, disrupting its normal functions. PLEKHM2 itself contains several domains, including a Pleckstrin homology (PH) domain, a RAB7-binding domain, and a coiled-coil domain, all of which are essential for its cellular functions. PLEKHM2 inhibitors are designed to interfere with these domains, either by binding to them directly or by modulating their activity. By doing so, these inhibitors can hinder the interactions of PLEKHM2 with other cellular components, leading to a disruption in vesicle trafficking and autophagy pathways. Researchers use PLEKHM2 inhibitors as powerful tools to unravel the intricacies of these processes, shedding light on fundamental cellular mechanisms and implications in various physiological and pathological conditions.

In summary, PLEKHM2 inhibitors represent a significant class of chemical compounds utilized in cellular and molecular research to investigate the role of PLEKHM2 in intracellular transport and autophagy. These inhibitors function by disrupting specific domains within the PLEKHM2 protein, ultimately influencing cellular processes.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Binds to the V-ATPase complex, inhibiting lysosomal acidification and autophagy.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$275.00
$928.00
$1543.00
14
(0)

Acts as a cysteine protease inhibitor, potentially disrupting Plekhm2-dependent processes.

NH125

278603-08-0sc-203037
5 mg
$187.00
1
(1)

Inhibits nucleoside diphosphate kinase activity, potentially affecting Plekhm2-mediated signaling.

Reversine

656820-32-5sc-203236
5 mg
$217.00
13
(1)

Suppresses phosphatidylinositol 3-kinase (PI3K) activity, potentially impacting Plekhm2 signaling.

U 18666A

3039-71-2sc-203306
sc-203306A
10 mg
50 mg
$140.00
$500.00
2
(1)

Inhibits cholesterol transport, potentially disrupting Plekhm2's role in cholesterol homeostasis.

SAR405

1523406-39-4sc-507416
1 mg
$125.00
(0)

Inhibits the autophagy kinase Vps34, which may indirectly impact Plekhm2-mediated autophagy processes.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$215.00
$622.00
5
(1)

Blocks Ras protein prenylation, potentially affecting Ras-mediated pathways involving Plekhm2.

Spautin-1

1262888-28-7sc-507306
10 mg
$165.00
(0)

Suppresses USP10 and USP13 deubiquitinase activity, potentially affecting Plekhm2-associated processes.

PIK-75, hydrochloride

372196-77-5sc-296089
sc-296089A
1 mg
5 mg
$28.00
$122.00
(1)

Selectively inhibits the PI3Kα isoform, impacting PI3K signaling pathways that Plekhm2 may participate in.

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$30.00
$125.00
$445.00
45
(1)

A p38 MAP kinase inhibitor that could affect Plekhm2 signaling through the p38 pathway.